By binding to PSIP1, circRNA‐mTOR affects the nuclear translocation of PSIP1 and promotes HCC progression and lenvatinib resistance via the PSIP1/c‐Myc axis. The gene discussed is PSIP1; the disease is hepatocellular carcinoma.